Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort study

Authors: Kyoung-Ho Song, Eu Suk Kim, Hye-yun Sin, Kyung-Hwa Park, Sook-In Jung, Nara Yoon, Dong-Min Kim, Chang Seop Lee, Hee-Chang Jang, Yoonseon Park, Kkot Sil Lee, Yee Gyung Kwak, Jae Hoon Lee, Seong Yeon Park, Minkyo Song, Sue K Park, Yeong-Seon Lee, Hong Bin Kim, Korea INfectious Diseases (KIND) study group

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Despite the importance of invasive Staphylococcus aureus (ISA) infection, its overall burden in non-selected populations has only been defined in a small number of studies in Europe and North America. To define the characteristics of ISA infections in Korea, we conducted a multi-center cohort study to estimate population-based incidence rates.

Methods

We conducted a multicenter prospective cohort study at nine university-affiliated active-surveillance core centers (ASCs) in three regions of Korea. To cover all available clinical microbiologic laboratories, we classified the laboratories in these regions into three groups according to their clinical environment as: 1) Nine ASCs, 2) Five major commercial laboratories and 3) Forty-four acute-care hospital-affiliated microbiology laboratories. We requested all the laboratories to report prospectively their numbers of cases of S. aureus isolated from normally sterile sites. Detailed clinical information was collected about the cases in the nine ASCs.

Results

From 1 July 2009 to 30 June 2011, a total of 1,198 cases of ISA infection were identified at the nine ASCs, including 748 (62%) methicillin-resistant S. aureus (MRSA) infections. Most (81%) ISA infections were healthcare-associated (HCA): 653 (55%) hospital-onset and 322 (27%) community-onset. 223 (19%) were community-associated infections. The most common primary diagnosis was catheter-associated infection (225 cases, 19%). Respiratory tract infection (160, 13%), skin & soft tissue (152, 13%) and bone & joint infections (120, 10%) were also common. 30-day and 12-week mortality rates were 25.6% (262/1,024) and 36.5% (314/860), respectively. Complications, including metastatic infection within 12 weeks, occurred in 17.8% of ISA infections. The most common site of metastatic infection was the lung (9.8%, 84/860). Based on the total of 2,806 observed cases of ISA infection, estimated annual rates of ISA and invasive MRSA infections were 43.3 and 27.7 per 100,000 populations, respectively.

Conclusions

Our data provide important information about the clinical characteristics of ISA infections. We estimate that over 21,000 ISA infections and 13,000 invasive MRSA infections occurred in Korea in 2010.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lowy FD: Staphylococcus aureus infections. N Engl J Med. 1998, 339 (8): 520-532. 10.1056/NEJM199808203390806.CrossRefPubMed Lowy FD: Staphylococcus aureus infections. N Engl J Med. 1998, 339 (8): 520-532. 10.1056/NEJM199808203390806.CrossRefPubMed
2.
go back to reference Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH: Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care. 2006, 10 (3): R97-10.1186/cc4934.CrossRefPubMedPubMedCentral Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH: Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care. 2006, 10 (3): R97-10.1186/cc4934.CrossRefPubMedPubMedCentral
3.
go back to reference Kim ES, Song JS, Lee HJ, Choe PG, Park KH, Cho JH, Park WB, Kim SH, Bang JH, Kim DM, et al: A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea. J Antimicrob Chemother. 2007, 60 (5): 1108-1114. 10.1093/jac/dkm309.CrossRefPubMed Kim ES, Song JS, Lee HJ, Choe PG, Park KH, Cho JH, Park WB, Kim SH, Bang JH, Kim DM, et al: A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea. J Antimicrob Chemother. 2007, 60 (5): 1108-1114. 10.1093/jac/dkm309.CrossRefPubMed
4.
go back to reference Kim HB, Jang HC, Nam HJ, Lee YS, Kim BS, Park WB, Lee KD, Choi YJ, Park SW, Oh MD, et al: In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey. Antimicrob Agents Chemother. 2004, 48 (4): 1124-1127. 10.1128/AAC.48.4.1124-1127.2004.CrossRefPubMedPubMedCentral Kim HB, Jang HC, Nam HJ, Lee YS, Kim BS, Park WB, Lee KD, Choi YJ, Park SW, Oh MD, et al: In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey. Antimicrob Agents Chemother. 2004, 48 (4): 1124-1127. 10.1128/AAC.48.4.1124-1127.2004.CrossRefPubMedPubMedCentral
5.
go back to reference Morin CA, Hadler JL: Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis. 2001, 184 (8): 1029-1034. 10.1086/323459.CrossRefPubMed Morin CA, Hadler JL: Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis. 2001, 184 (8): 1029-1034. 10.1086/323459.CrossRefPubMed
6.
go back to reference El Atrouni WI, Knoll BM, Lahr BD, Eckel-Passow JE, Sia IG, Baddour LM: Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2009, 49 (12): e130-e138. 10.1086/648442.CrossRef El Atrouni WI, Knoll BM, Lahr BD, Eckel-Passow JE, Sia IG, Baddour LM: Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2009, 49 (12): e130-e138. 10.1086/648442.CrossRef
7.
go back to reference Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, Dumyati G, et al: Health care-associated invasive MRSA infections, 2005-2008. JAMA: J Am Med Assoc. 2010, 304 (6): 641-648. 10.1001/jama.2010.1115.CrossRef Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, Dumyati G, et al: Health care-associated invasive MRSA infections, 2005-2008. JAMA: J Am Med Assoc. 2010, 304 (6): 641-648. 10.1001/jama.2010.1115.CrossRef
8.
go back to reference Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD: Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis. 2003, 187 (9): 1452-1459. 10.1086/374621.CrossRefPubMed Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD: Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis. 2003, 187 (9): 1452-1459. 10.1086/374621.CrossRefPubMed
9.
go back to reference Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, et al: Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA: J Am Med Assoc. 2007, 298 (15): 1763-1771. 10.1001/jama.298.15.1763.CrossRef Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, et al: Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA: J Am Med Assoc. 2007, 298 (15): 1763-1771. 10.1001/jama.298.15.1763.CrossRef
10.
go back to reference Laupland KB: Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect: Offic Publ Eur Soc Clin Microbiol Infect Dis. 2013, 19 (6): 492-500.CrossRef Laupland KB: Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect: Offic Publ Eur Soc Clin Microbiol Infect Dis. 2013, 19 (6): 492-500.CrossRef
11.
12.
go back to reference The Korean Association of Quality Assurance for Clinical Laboratory: List of participating hospitals, Committee of Clinical Microbiology. Availabe at: http://www.lab-qa.org (last accessed 25 March 2013) The Korean Association of Quality Assurance for Clinical Laboratory: List of participating hospitals, Committee of Clinical Microbiology. Availabe at: http://​www.​lab-qa.​org (last accessed 25 March 2013)
13.
go back to reference Jang HC, Kim SH, Kim KH, Kim CJ, Lee S, Song KH, Jeon JH, Park WB, Kim HB, Park SW, et al: Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2009, 49 (3): 395-401. 10.1086/600295.CrossRef Jang HC, Kim SH, Kim KH, Kim CJ, Lee S, Song KH, Jeon JH, Park WB, Kim HB, Park SW, et al: Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2009, 49 (3): 395-401. 10.1086/600295.CrossRef
14.
go back to reference Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ: Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2008, 46 (7): 1000-1008. 10.1086/529190.CrossRef Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ: Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2008, 46 (7): 1000-1008. 10.1086/529190.CrossRef
15.
go back to reference Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO: Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2001, 32 (8): 1162-1171. 10.1086/319757.CrossRef Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO: Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2001, 32 (8): 1162-1171. 10.1086/319757.CrossRef
16.
go back to reference Fowler VG, Justice A, Moore C, Benjamin DK, Woods CW, Campbell S, Reller LB, Corey GR, Day NP, Peacock SJ: Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2005, 40 (5): 695-703. 10.1086/427806.CrossRef Fowler VG, Justice A, Moore C, Benjamin DK, Woods CW, Campbell S, Reller LB, Corey GR, Day NP, Peacock SJ: Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2005, 40 (5): 695-703. 10.1086/427806.CrossRef
17.
go back to reference Joseph JP, Meddows TR, Webster DP, Newton JD, Myerson SG, Prendergast B, Scarborough M, Herring N: Prioritizing echocardiography in Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2013, 68 (2): 444-449. 10.1093/jac/dks408.CrossRefPubMed Joseph JP, Meddows TR, Webster DP, Newton JD, Myerson SG, Prendergast B, Scarborough M, Herring N: Prioritizing echocardiography in Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2013, 68 (2): 444-449. 10.1093/jac/dks408.CrossRefPubMed
18.
go back to reference Rasmussen RV, Host U, Arpi M, Hassager C, Johansen HK, Korup E, Schonheyder HC, Berning J, Gill S, Rosenvinge FS, et al: Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography. Eur J Echocardiogr: J Working Group Echocardiogr Eur Soc Cardiol. 2011, 12 (6): 414-420. 10.1093/ejechocard/jer023.CrossRef Rasmussen RV, Host U, Arpi M, Hassager C, Johansen HK, Korup E, Schonheyder HC, Berning J, Gill S, Rosenvinge FS, et al: Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography. Eur J Echocardiogr: J Working Group Echocardiogr Eur Soc Cardiol. 2011, 12 (6): 414-420. 10.1093/ejechocard/jer023.CrossRef
19.
go back to reference Chang FY, Peacock JE, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O’Donnell A, Wagener MM, Yu VL: Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine. 2003, 82 (5): 333-339. 10.1097/01.md.0000091184.93122.09.CrossRefPubMed Chang FY, Peacock JE, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O’Donnell A, Wagener MM, Yu VL: Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine. 2003, 82 (5): 333-339. 10.1097/01.md.0000091184.93122.09.CrossRefPubMed
20.
go back to reference Laupland KB, Ross T, Gregson DB: Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis. 2008, 198 (3): 336-343. 10.1086/589717.CrossRefPubMed Laupland KB, Ross T, Gregson DB: Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis. 2008, 198 (3): 336-343. 10.1086/589717.CrossRefPubMed
21.
go back to reference Mylotte JM, Tayara A: Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2000, 31 (5): 1170-1174. 10.1086/317421.CrossRef Mylotte JM, Tayara A: Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis: Offic Publ Infect Dis Soc Am. 2000, 31 (5): 1170-1174. 10.1086/317421.CrossRef
22.
go back to reference Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhoj P, Frimodt-Moller N: Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med. 2002, 162 (1): 25-32. 10.1001/archinte.162.1.25.CrossRefPubMed Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhoj P, Frimodt-Moller N: Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med. 2002, 162 (1): 25-32. 10.1001/archinte.162.1.25.CrossRefPubMed
23.
go back to reference Conterno LO, Wey SB, Castelo A: Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Contr Hospital Epidemiol: Offic J Soc Hospital Epidemiol Am. 1998, 19 (1): 32-37. 10.1086/647704.CrossRef Conterno LO, Wey SB, Castelo A: Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Contr Hospital Epidemiol: Offic J Soc Hospital Epidemiol Am. 1998, 19 (1): 32-37. 10.1086/647704.CrossRef
24.
go back to reference Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ: Population-based assessment of intensive care unit-acquired bloodstream infections in adults: Incidence, risk factors, and associated mortality rate. Crit Care Med. 2002, 30 (11): 2462-2467. 10.1097/00003246-200211000-00010.CrossRefPubMed Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ: Population-based assessment of intensive care unit-acquired bloodstream infections in adults: Incidence, risk factors, and associated mortality rate. Crit Care Med. 2002, 30 (11): 2462-2467. 10.1097/00003246-200211000-00010.CrossRefPubMed
25.
go back to reference Laupland KB, Lyytikainen O, Sogaard M, Kennedy KJ, Knudsen JD, Ostergaard C, Galbraith JC, Valiquette L, Jacobsson G, Collignon P, et al: The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect: Offic Publ Eur Soc Clin Microbiol Infect Dis. 2013, 19 (5): 465-471.CrossRef Laupland KB, Lyytikainen O, Sogaard M, Kennedy KJ, Knudsen JD, Ostergaard C, Galbraith JC, Valiquette L, Jacobsson G, Collignon P, et al: The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect: Offic Publ Eur Soc Clin Microbiol Infect Dis. 2013, 19 (5): 465-471.CrossRef
26.
go back to reference Tong SY, Bishop EJ, Lilliebridge RA, Cheng AC, Spasova-Penkova Z, Holt DC, Giffard PM, McDonald MI, Currie BJ, Boutlis CS: Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis. 2009, 199 (10): 1461-1470. 10.1086/598218.CrossRefPubMed Tong SY, Bishop EJ, Lilliebridge RA, Cheng AC, Spasova-Penkova Z, Holt DC, Giffard PM, McDonald MI, Currie BJ, Boutlis CS: Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis. 2009, 199 (10): 1461-1470. 10.1086/598218.CrossRefPubMed
27.
go back to reference Jacobsson G, Dashti S, Wahlberg T, Andersson R: The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis. 2007, 39 (1): 6-13. 10.1080/00365540600810026.CrossRefPubMed Jacobsson G, Dashti S, Wahlberg T, Andersson R: The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis. 2007, 39 (1): 6-13. 10.1080/00365540600810026.CrossRefPubMed
28.
go back to reference Huggan PJ, Wells JE, Browne M, Richardson A, Murdoch DR, Chambers ST: Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand. Intern Med J. 2010, 40 (2): 117-125. 10.1111/j.1445-5994.2009.01910.x.CrossRefPubMed Huggan PJ, Wells JE, Browne M, Richardson A, Murdoch DR, Chambers ST: Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand. Intern Med J. 2010, 40 (2): 117-125. 10.1111/j.1445-5994.2009.01910.x.CrossRefPubMed
29.
go back to reference Steckelberg JM, Melton LJ, Ilstrup DM, Rouse MS, Wilson WR: Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med. 1990, 88 (6): 582-588. 10.1016/0002-9343(90)90521-E.CrossRefPubMed Steckelberg JM, Melton LJ, Ilstrup DM, Rouse MS, Wilson WR: Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med. 1990, 88 (6): 582-588. 10.1016/0002-9343(90)90521-E.CrossRefPubMed
31.
go back to reference Kim EC, Shin JH, Kim S, Lee NY, Cho JH, Koo SH, Ryoo NH, Joo SI: Number of blood cultures per 1,000 patient days at university-affiliated hospitals in Korea. Korean J Clin Microbiol. 2012, 15 (2): 67-69. 10.5145/KJCM.2012.15.2.67.CrossRef Kim EC, Shin JH, Kim S, Lee NY, Cho JH, Koo SH, Ryoo NH, Joo SI: Number of blood cultures per 1,000 patient days at university-affiliated hospitals in Korea. Korean J Clin Microbiol. 2012, 15 (2): 67-69. 10.5145/KJCM.2012.15.2.67.CrossRef
32.
go back to reference Baron EJ, Weinstein MP, Dunne WM, Yagupsky P, Welch DF, Wilson DM: Cumitech 1C: blood cultures IV. 2005, Washington, DC: ASM Press Baron EJ, Weinstein MP, Dunne WM, Yagupsky P, Welch DF, Wilson DM: Cumitech 1C: blood cultures IV. 2005, Washington, DC: ASM Press
Metadata
Title
Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort study
Authors
Kyoung-Ho Song
Eu Suk Kim
Hye-yun Sin
Kyung-Hwa Park
Sook-In Jung
Nara Yoon
Dong-Min Kim
Chang Seop Lee
Hee-Chang Jang
Yoonseon Park
Kkot Sil Lee
Yee Gyung Kwak
Jae Hoon Lee
Seong Yeon Park
Minkyo Song
Sue K Park
Yeong-Seon Lee
Hong Bin Kim
Korea INfectious Diseases (KIND) study group
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-581

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine